CM-AVM2 is caused by LOF mutations in the transmembrane receptor EPHB4 that is expressed on venous cells, which interacts with p120RasGAP to inhibit the RAS/MAPK/ERK signaling pathway. This evidence concerns the gene RASA1 and cutaneous mastocytosis.